光热治疗
体内
骨肉瘤
癌症研究
诱导剂
体外
细胞内
细胞
纳米颗粒
化学
纳米技术
材料科学
医学
生物
生物化学
生物技术
基因
作者
Yujie Liu,Suhe Dong,Wenhao Hu,Qiaoling Chen,S.H. Zhang,Kai Song,Zhen-chuan Han,Mengmeng Li,Zhitao Han,Weibo Liu,Xuesong Zhang
标识
DOI:10.1016/j.bioactmat.2024.02.007
摘要
Much effort has been devoted to improving treatment efficiency for osteosarcoma (OS). However, most current approaches result in poor therapeutic responses, thus indicating the need for the development of other therapeutic options. This study developed a multifunctional nanoparticle, PDA-MOF-E-M, an aggregation of OS targeting, programmed death targeting, and near-infrared (NIR)-aided targeting. At the same time, a multifunctional nanoparticle that utilises Fe-MOFs to create a cellular iron-rich environment and erastin as a ferroptosis inducer while ensuring targeted delivery to OS cells through cell membrane encapsulation is presented. The combination of PDA-MOF-E-M and PTT increased intracellular ROS and LPO levels and induced ferroptosis-related protein expression. A PDA-based PTT combined with erastin showed significant synergistic therapeutic improvement in the anti-tumour efficiency of the nanoparticle in vitro and vivo. The multifunctional nanoparticle efficiently prevents the osteoclasia progression of OS xenograft bone tumors in vivo. Finally, this study provides guidance and a point of reference for clinical approaches to treating OS.
科研通智能强力驱动
Strongly Powered by AbleSci AI